Advertisement
Screener

ONEMEDNET CORPORATION (ONMD) Graph

ONMD Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2021-03-31: Net income -$845.00.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ONMD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Data Delivery Revenue$292.00KRevenue$292.00KCost of revenue$857.00KGross profit-$565.00KOperating expenses$1.70MOperating income-$2.26MOther income, net$2.00KResearch & development$324.00KNet income-$2.17M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ONMD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Americas$99.00KRest Of World$193.00KRevenue$292.00KCost of revenue$857.00KGross profit-$565.00KOperating expenses$1.70MOperating income-$2.26MOther income, net$2.00KResearch & development$324.00KNet income-$2.17M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 2 month

Period endNet income
2021-03-31-$845.00

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$292.00K$857.00K$324.00K$1.70M(m)-$2.17M
2026-03-31$96.00K$476.00K$311.00K$2.17M(m)-$2.45M
2025-09-30$177.00K$399.00K$323.00K$2.01M(m)-$741.00K
2025-06-30$155.00K$396.00K$382.00K$1.82M(m)$2.98M
2025-03-31$137.00K$361.00K$348.00K$2.00M(m)-$1.90M
2024-09-30$142.00K$226.00K$298.00K$2.25M(m)-$2.06M
2024-06-30$227.00K$329.00K$383.00K$2.35M(m)-$3.59M
2024-03-31$248.00K$317.00K$445.00K$2.03M(m)-$2.11M
2023-09-30$326.00K$293.00K$405.00K$1.96M$87.71K-$13.84M
2023-06-30$173.00K$230.00K$579.00K$1.51M$62.71K-$9.60M
2023-03-31$200.00K$289.00K$582.00K$1.38M$59.60K-$7.84M
2022-09-30$375.00K$474.00K$597.00K$2.84M$106.72K-$8.74M
2022-06-30(m)(m)(m)(m)(m)$949.94K
2022-03-31(m)(m)(m)(m)(m)$2.20M
2021-09-30(m)(m)(m)(m)(m)$1.29M
2021-06-30(m)(m)(m)(m)(m)$4.31M

Revenue and expense 5 month

Period endNet income
2021-06-30$4.31M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$388.00K$1.54M$636.00K$3.66M(m)-$4.63M
2025-06-30$292.00K$737.00K$749.00K$3.91M(m)$1.08M
2024-06-30$476.00K$646.00K$828.00K$4.38M(m)-$5.70M
2023-06-30$356.00K$519.00K$1.16M$2.90M$122.30K-$17.44M
2022-06-30(m)(m)(m)(m)(m)$3.15M

Revenue and expense 8 month

Period endNet income
2021-09-30$5.60M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$468.00K$1.14M$1.07M$5.92M(m)$339.00K
2024-09-30$617.00K$872.00K$1.13M$6.63M(m)-$7.76M
2023-09-30$681.00K$812.00K$1.57M$4.85M$210.02K-$31.28M
2022-09-30$889.00K$1.11M$1.09M$5.63M$106.72K-$22.40M

Revenue and expense 11 month

Period endNet income
2021-12-31$5.14M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$1.36M$1.86M$1.51M$9.16M$1.00K-$2.80M
2024-12-31$643.00K$924.00K$1.47M$9.32M$2.00K-$10.13M
2023-12-31$1.02M$1.15M$2.06M$6.72M$18.00K-$33.78M
2022-12-31$1.15M$1.51M$1.59M$7.36M$17.00K-$30.45M

Similar stocks

Stock NameCountryMarket CapPE Ratio
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14